Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/02/040338
CTRI/2022/02/040338
Completed
未知

Evaluation of dermatological safety of test products by primary irritation patch test on healthy human volunteers of varied skin types

Arbro pharmaceutical Pvt Ltd0 sites24 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Arbro pharmaceutical Pvt Ltd
Enrollment
24
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 22, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Arbro pharmaceutical Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • •1\.Healthy male and female subjects in the age
  • •group of 18\-55 years(both age inclusive)
  • •2\. Subject is having valid proof of
  • •identity and age
  • •3\. Subjects with skin phototype III to V
  • •4\.Subject is having apparently healthy skin on
  • •5\.Subject representing normal, oily, dry and
  • •combination skin type in nearly equal ratio
  • •6\.Subject willing to give a voluntary written
  • •informed consent

Exclusion Criteria

  • •1\. Subjects with Known hypersensitivity to any of
  • •the study products or constituents
  • •2\. Subjects having any significant pathology in
  • •the test area
  • •3\. Subjects with any kind of skin allergy,
  • •antecedents or cutaneous disease which may
  • •influence the study results
  • •4\. Subjects having topical or systemic treatment
  • •in last month prior to participation in the
  • •study and during the study that could interfere

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Safety testing of cosmetic products by patch test
CTRI/2021/12/038826Arbro pharmaceutical Pvt Ltd24
Completed
Not Applicable
Safety testing of cosmetic products by PIPT(Primary Irritation Patch Test)
CTRI/2022/02/039947Arbro pharmaceutical Pvt Ltd24
Not yet recruiting
Not Applicable
To check dermatological safety of test products by 24 hours patch test on adult healthy human subjects
CTRI/2024/06/069652Kayura Effect LLP
Completed
Not Applicable
Check of safety of test product by applying patch on healthy human of different skin types
CTRI/2023/03/050596SilkLyfe24
Completed
Not Applicable
Safety testing of cosmetic products by primary irritation patch tests
CTRI/2022/01/039814Asclepius Wellness Pvt Ltd24